EUVIMEDEUVIMED entdecken
Crossref

Multiform structure-based identification of natural phytochemical inhibitors targeting RAMP1 for migraine therapy

Bibi Haleema

Biomedical Letters · 17.07.2026 · 12 (1) · 73

DOI: 10.47262/bl/12.1.20260402 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Letters, online erschienen am 17.07.2026. Verfasst von Bibi Haleema. Die Arbeit nennt 39 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Migraine is a prevalent neurological disorder primarily driven by activation of calcitonin gene-related peptide (CGRP) receptor system, in which receptor activity modifying protein 1 (RAMP1) plays a critical structural and functional role in stabilizing CGRP receptor complex. In this analysis, an in-silico drug designing approach was utilized for the identification of naturally existing phytochemicals that have strong inhibitory activity against RAMP-1. In present study, an in-silico drug discovery approach was employed to identify naturally occurring phytochemicals with potential inhibitory activity against RAMP1. The three-dimensional structure of RAMP1 was retrieved and prepared for molecular docking analysis, while twenty-five phytochemicals with reported anti-inflammatory properties were selected as candidate ligands. Molecular docking was performed to evaluate the binding affinity and protein-ligand interactions. Ursonic acid exhibited highest binding affinity (-7.8kcal/mol), followed by rutin (-7.1 kcal/mol) and β-sitosterol (-7.0 kcal/mol). Interaction analysis of the docked complexes identified 36 unique amino acid residues involved in ligand binding with Tyr-66, Trp-84, Pro85, Val-89, Asp-90, Phe-93 and His-97. ADMET analysis revealed that 23 of the 25 compounds compiled with Lipinski’s Rule of Five. By integrating molecular docking with pharmacokinetics and toxicity predictions, ursonic acid and β-sitosterol were identified as the most significant phytochemical candidates for further analysis as potential RAMP1 target as anti-migraine agent.

Zitieren

APA

Haleema, B. (2026). Multiform structure-based identification of natural phytochemical inhibitors targeting RAMP1 for migraine therapy. Biomedical Letters, 12(1), 73. https://doi.org/10.47262/bl/12.1.20260402

Vancouver

Haleema B. Multiform structure-based identification of natural phytochemical inhibitors targeting RAMP1 for migraine therapy. Biomedical Letters. 2026;12(1):73. doi:10.47262/bl/12.1.20260402

BibTeX
@article{Haleema2026,
  author = {Haleema, Bibi},
  title = {Multiform structure-based identification of natural phytochemical inhibitors targeting RAMP1 for migraine therapy},
  journal = {Biomedical Letters},
  year = {2026},
  volume = {12},
  number = {1},
  pages = {73},
  doi = {10.47262/bl/12.1.20260402}
}
Kostenlos starten →